Griffin Asset Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,965
Closed -$49.4K 210
2024
Q4
$49.4K Buy
2,965
+147
+5% +$1.83K 0.01% 211
2024
Q3
$28.6K Sell
2,818
-4,216
-60% -$125K ﹤0.01% 209
2024
Q2
$406K Buy
7,034
+506
+8% +$24.8K 0.05% 168
2024
Q1
$217K Buy
6,528
+354
+6% +$17.9K 0.03% 213
2023
Q4
$501K Buy
6,174
+2,946
+91% +$240K 0.06% 162
2023
Q3
$527K Sell
3,228
-123
-4% -$29K 0.07% 157
2023
Q2
$1.1M Buy
3,351
+245
+8% +$74.7K 0.15% 128
2023
Q1
$857K Buy
3,106
+245
+9% +$89.9K 0.12% 139
2022
Q4
$1.11M Buy
2,861
+187
+7% +$52.7K 0.17% 126
2022
Q3
$639K Buy
2,674
+64
+2% +$17.1K 0.11% 146
2022
Q2
$582K Buy
2,610
+472
+22% +$203K 0.09% 154
2022
Q1
$1.46M Sell
2,138
-19
-0.9% -$11.4K 0.19% 113
2021
Q4
$1.49M Sell
2,157
-95
-4% -$70.3K 0.19% 114
2021
Q3
$1.67M Buy
+2,252
New +$1.53M 0.21% 111

Other funds holding OM

Griffin Asset Management's OM Position: Q1 2025 in Review

Griffin Asset Management sold out of Outset Medical (OM) in Q1 2025, closing a stake of 2,965 shares — an estimated $49.4K sold.

Griffin Asset Management first reported a position in OM in Q3 2021 and held it in 14 quarters. The position peaked at $1.67M in Q3 2021. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

  • Griffin Asset Management reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
  • Griffin Asset Management sold 2,965 Outset Medical shares in Q1 2025, an estimated $49.4K.
  • Griffin Asset Management first reported a position in Outset Medical in Q3 2021 and held it in 14 quarters.
  • Griffin Asset Management's Outset Medical position peaked at $1.67M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on Griffin Asset Management's 13F filing for Q1 2025, filed 16 Apr 2025.